exprerimental group:Venetoclax, azacitidine, combined with low-dose cytarabine

Venetoclax, azacitidine, combined with low-dose cytarabine in treatment-naive, elderly or unfit patients with acute myeloid leukemia

Comparison of efficacy and safety between Venetoclax, azacitidine (VA) and VA combined with low-dose cytarabine (VAA) in treatment-naive, elderly patients with acute myeloid leukemia: a randomized controlled trial